Amy S. Broidrick - 08 Dec 2021 Form 4 Insider Report for Qualigen Therapeutics, Inc. (QLGN)

Role
President/ChiefStrategyOfficer, Director
Signature
/s/ Hayden Trubitt, Attorney-in-Fact for Amy S. Broidrick
Issuer symbol
QLGN
Transactions as of
08 Dec 2021
Net transactions value
$0
Form type
4
Filing time
10 Dec 2021, 05:15:10 UTC
Next filing
15 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QLGN Common Stock 4,500 08 Dec 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QLGN Stock Option (Right to Buy) Award $0 +300,000 $0.000000 300,000 08 Dec 2021 Common Stock 300,000 $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares underlying the stock option vest over three years in three equal annual installments from the date of grant.